1. Abdullozoda S.M. Prevalence of obesity among the adult population of the Republic of Tajikistan. Avicenna Bulletin. 2022;24(1):19-28. doi: 10.25005/2074-0581-2022-24-1-19-28.
2. Abdullozoda S.M., Usmanova G.M. Screening for obesity in the adult population of Tajikistan: a pilot project in selected areas. Avicenna Bulletin. 2023;25(3):356-369. doi: 10.25005/2074-0581-2023-25-3-356-369.
3. World Health Organization. Obesity and overweight: fact sheet. Geneva: WHO; 2024.
4. World Health Organization. European regional report on risk factors for noncommunicable diseases. Copenhagen: WHO Regional Office for Europe; 2023.
5. Khairov H.S., Sharifzoda S.F., Khairova M.Kh. Overweight and prevalence of obesity among women of reproductive age in the Republic of Tajikistan. Ilm-Tahsilot. 2024;1(4):515-530. doi: 10.25005/3078-5022-2024-1-4-515-530.
6. Khakimzoda B.Kh., Rakhmonov D.A. Experience of minimally invasive interventions for obesity in the Republic of Tajikistan. Plastic Surgery and Reconstructive Medicine. 2025;1(1):6-15. doi: 10.65197/3106-4035-2025-1-1-6-15.
7. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. New England Journal of Medicine. 2017;377(1):13-27.
8. Hall J.E., do Carmo J.M., da Silva A.A., Wang Z., Hall M.E. Obesity, kidney dysfunction and hypertension: mechanistic links. Nature Reviews Nephrology. 2019;15(6):367-385.
9. Hall K.D., Kahan S. Maintenance of lost weight and long-term management of obesity. Medical Clinics of North America. 2018;102(1):183-197.
10. Hruby A., Hu F.B. The epidemiology of obesity: a big picture. Pharmacoeconomics. 2015;33(7):673-689.
11. Thapa S., Ahmed K.Y., Bizuayehu H.M., Huda M.M., Chalise B., Bore M.G., Ross A.G. Trends and social determinants of the obesity epidemic among reproductive-age women in ten Asian countries. Scientific Reports. 2024;14(1):22545.
12. Abarca-Gómez L., Abdeen Z.A., Hamid Z.A., Abu-Rmeileh N.M., Acosta-Cazares B., Acuin C., Cho Y. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. The Lancet. 2017;390(10113):2627-2642.
13. Ng M., Fleming T., Robinson M., Thomson B., Graetz N., Margono C., Gakidou E. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2014;384(9945):766-781.
14. Salari N., Hasheminezhad R., Sedighi T., Zarei H., Shohaimi S., Mohammadi M. The global prevalence of sexual dysfunction in obese and overweight women: a systematic review and meta-analysis. BMC Women's Health. 2023;23(1):375.
15. Swinburn B.A., Kraak V.I., Allender S., Atkins V.J., Baker P.I., Bogard J.R., Dietz W.H. The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. The Lancet. 2019;393(10173):791-846.
16. World Obesity Federation. World Obesity Atlas 2024. London: World Obesity Federation; 2024.
17. World Health Organization. Global report on diabetes. Geneva: WHO; 2023.
18. Ismoilov M.M., Saidov M.S., Radzhabov M.F. The influence of excess weight on the results of breast reduction. Eurasian Scientific Medical Journal "Sino". 2025;6(1-2):44-46.
19. Saidov M.S. Reduction mammoplasty and obesity: is there a mutual influence? Bulletin of Surgut State University. Medicine. 2024;17(1):58-61.
20. Khodjamuradov G.M., Shaimanov A.Kh., Saidov M.S., Shamsov N.Kh., Mirzoev N.M. Gastric surgery and other types of surgical interventions for obesity: comparative evaluation of results. Eurasian Scientific Medical Journal "Sino". 2024;5(1):47-54.
21. Kokkorakis M., Chakhtoura M., Rhayem C., Al Rifai J., Ghezzawi M., Valenzuela-Vallejo L., Mantzoros C.S. Emerging pharmacotherapies for obesity: a systematic review. Pharmacological Reviews. 2025;77(1):100002.
22. Rubino F., Cummings D.E., Eckel R.H., Cohen R.V., Wilding J.P., Brown W.A., Mingrone G. Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology. 2025;13(3):221-262.
23. Ahmed S.K., Mohammed R.A. Obesity: prevalence, causes, consequences, management, preventive strategies and future research directions. Metabolism Open. 2025;27:100375.
24. Blüher M. An overview of obesity-related complications: the epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes. Diabetes, Obesity and Metabolism. 2025;27:3-19.
25. Fourman L.T., Awwad A., Gutiérrez-Sacristán A., Dash C.A., Johnson J.E., Thistle A.K., Grinspoon S.K. Implications of a new obesity definition among the All of Us cohort. JAMA Network Open. 2025;8(10):e2537619.
26. Soták M., Clark M., Suur B.E., Börgeson E. Inflammation and resolution in obesity. Nature Reviews Endocrinology. 2025;21(1):45-61.
27. Janić M., Janež A., El-Tanani M., Rizzo M. Obesity: recent advances and future perspectives. Biomedicines. 2025;13(2):368.
28. McGowan B., Ciudin A., Baker J.L., Busetto L., Dicker D., Frühbeck G., Yumuk V. Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO). Nature Medicine. 2025;31(10):3229-3232.
29. Yao Z., Tchang B.G., Albert M., Blumenthal R.S., Nasir K., Blaha M.J. Associations between class I, II, or III obesity and health outcomes. NEJM Evidence. 2025;4(4):EVIDoa2400229.
30. Koskinas K.C., Van Craenenbroeck E.M., Antoniades C., Blüher M., Gorter T.M., Hanssen H., Prescott E.B. Obesity and cardiovascular disease: an ESC clinical consensus statement. European Journal of Preventive Cardiology. 2025;32(3):184-220.